Xi, Guifa <br/><br/>
Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy.  [electronic resource] 

 -  Molecular cancer  01 2017 
 - 21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/s12943-017-0593-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen--antagonists & inhibitors<br/>ATP Binding Cassette Transporter, Subfamily B--metabolism<br/>Adolescent<br/>Astrocytoma--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Chemotherapy, Adjuvant<br/>Child<br/>Child, Preschool<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Infant<br/>Male<br/>NF-kappa B--genetics<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local--drug therapy<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Signal Transduction<br/>Up-Regulation